Skip to main content

Diagnostic options · UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 916–930 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-6233
SLC16A1 Gene Hyperinsulinemic Hypoglycemia Type 7 Genetic Test

This test identifies genetic mutations in the SLC16A1 gene associated with congenital hyperinsulinemic hypoglycemia type 7.

Whole blood (EDTA) or dried blood spot on FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC16A1 gene", "Mutation types (missense, nonsense, frameshift, splice-site)"]
Parameters
[]
Preparation
["Inform phlebotomist of all current medications", "No specific fasting required for blood draw"]
Indications
["Suspected congenital hyperinsulinemic hypoglycemia type 7", "Familial history of hyperinsulinemic hypoglycemia", "Need for definitive molecular diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82619-4 ICD-10: E16.1
Clinical summary
This test identifies genetic mutations in the SLC16A1 gene associated with congenital hyperinsulinemic hypoglycemia type 7.
TEST-5952
SLC16A1 Gene Monocarboxylate Transporter 1 Deficiency Genetic Test

This genetic test identifies pathogenic variants in the SLC16A1 gene associated with Monocarboxylate Transporter 1 deficiency.

Whole Blood (EDTA), Extracted DNA, or FTA Card 21 – 28 days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC16A1 gene", "SNVs", "Indels", "CNVs"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Suspected Monocarboxylate Transporter 1 deficiency", "Family history of the disorder", "Unexplained exercise-induced metabolic crises"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 31209-3 ICD-10: E71.32
Clinical summary
This genetic test identifies pathogenic variants in the SLC16A1 gene associated with Monocarboxylate Transporter 1 deficiency.
TEST-5544
SLC16A2 Gene Pelizaeus‑Merzbacher Disease & Allan‑Herndon‑Dudley Syndrome Genetic Test

This genetic test evaluates the SLC16A2 (MCT8) gene for pathogenic variants associated with Pelizaeus‑Merzbacher disease and Allan‑Herndon‑Dudley syndrome.

Peripheral whole blood (EDTA) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC16A2 gene", "Full coding regions and splice sites"]
Parameters
[]
Preparation
["No fasting required", "No medication adjustment required unless instructed by physician"]
Indications
["Suspected Pelizaeus‑Merzbacher disease", "Suspected Allan‑Herndon‑Dudley syndrome", "Family history of SLC16A2-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82992-1 ICD-10: E71.1, E75.23
Clinical summary
This genetic test evaluates the SLC16A2 (MCT8) gene for pathogenic variants associated with Pelizaeus‑Merzbacher disease and Allan‑Herndon‑Dudley syndrome.
TEST-4378
SLC19A3 Gene Encephalopathy Thiamine-Responsive Genetic Test

This test identifies pathogenic variants in the SLC19A3 gene associated with thiamine-transporter-2 deficiency.

Whole Blood or Dried Blood Spot (FTA Card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC19A3 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected thiamine-transporter-2 deficiency", "Unexplained encephalopathy", "Family history of related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77074-2 ICD-10: E53.8
Clinical summary
This test identifies pathogenic variants in the SLC19A3 gene associated with thiamine-transporter-2 deficiency.
TEST-4390
SLC1A3 Gene Episodic Ataxia Type 6 Genetic Test

This test evaluates the SLC1A3 gene for mutations associated with Episodic Ataxia Type 6.

Whole Blood, Extracted DNA, or Dried Blood Spot on FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SLC1A3 gene coding region", "Copy Number Variations (CNV) in SLC1A3"]
Parameters
[]
Preparation
["Genetic counselling session required", "Clinical history must be provided"]
Indications
["Confirmation of clinical diagnosis of Episodic Ataxia Type 6", "Genetic risk assessment for family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94075-0 ICD-10: G11.8
Clinical summary
This test evaluates the SLC1A3 gene for mutations associated with Episodic Ataxia Type 6.
TEST-4156
SLC1A4 Gene Genetic Test for Developmental Delay & Microcephaly

This test evaluates the SLC1A4 gene for pathogenic variants associated with developmental delay and progressive microcephaly.

Whole Blood (EDTA) – 2 mL 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC1A4 gene", "Copy Number Variations (CNV) in the SLC1A4 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions"]
Indications
["Suspected SLC1A4-related disorder", "Developmental delay with microcephaly"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: Q02
Clinical summary
This test evaluates the SLC1A4 gene for pathogenic variants associated with developmental delay and progressive microcephaly.
TEST-3072
SLC20A2 Gene Idiopathic Basal Ganglia Calcification Type 1 Test

This diagnostic test evaluates the SLC20A2 gene for pathogenic variants associated with idiopathic basal ganglia calcification type 1 (Fahr's disease).

Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC20A2 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Individuals with progressive neurological symptoms", "Bilateral basal ganglia calcifications on neuroimaging", "Family history of Fahr's disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101376-5 ICD-10: G23.8
Clinical summary
This diagnostic test evaluates the SLC20A2 gene for pathogenic variants associated with idiopathic basal ganglia calcification type 1 (Fahr's disease).
TEST-6154
SLC22A12 Gene Hypouricemia, Renal Type 1 Genetic Test

This genetic test evaluates the SLC22A12 gene for mutations causing hereditary renal hypouricemia type 1.

Whole blood (EDTA), extracted DNA, or FTA card blood spot 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the SLC22A12 gene"]
Parameters
[]
Preparation
["No specific contraindications for sample collection", "Genetic counselling session must be completed"]
Indications
["Individuals with persistently low serum uric acid (
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E79.8
Clinical summary
This genetic test evaluates the SLC22A12 gene for mutations causing hereditary renal hypouricemia type 1.
TEST-6164
SLC25A15 Gene HHH Syndrome NGS Test

This test identifies pathogenic variants in the SLC25A15 gene associated with hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.

Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC25A15 gene", "Single nucleotide variants", "Small insertions", "Small deletions"]
Parameters
[]
Preparation
["No fasting or special preparation required"]
Indications
["Suspected HHH syndrome", "Family history of HHH syndrome", "Cascade screening for at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: E72.2, E72.29
Clinical summary
This test identifies pathogenic variants in the SLC25A15 gene associated with hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.
TEST-5913
SLC25A19 Gene (Thiamine Metabolism Dysfunction Syndrome 4, Progressive Polyneuropathy Type) Genetic Test

This genetic test evaluates the SLC25A19 gene for pathogenic variants associated with Thiamine Metabolism Dysfunction Syndrome 4 (progressive polyneuropathy type).

Whole blood (EDTA) or Dried Blood Spot (FTA card) 3–4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC25A19 gene", "Thiamine metabolism dysfunction"]
Parameters
[]
Preparation
["Pre-test genetic counselling is mandatory", "A three-generation pedigree chart is required"]
Indications
["Suspected hereditary peripheral neuropathy", "Clinical and neurophysiological findings suggesting a hereditary metabolic neuropathy", "Carrier screening in families with a known mutation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94455-4 ICD-10: E88.89
Clinical summary
This genetic test evaluates the SLC25A19 gene for pathogenic variants associated with Thiamine Metabolism Dysfunction Syndrome 4 (progressive polyneuropathy type).
TEST-6238
SLC26A3 Gene Congenital Secretory Chloride Diarrhea Type 1 Genetic Test

This diagnostic test evaluates the SLC26A3 gene for pathogenic mutations associated with congenital secretory chloride diarrhea type 1 (DIAR1).

Whole blood (EDTA) or dried blood spot (FTA card) 3–4 weeks from sample receipt (expedited neonatal reports available within 10 days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the SLC26A3 gene", "Copy number variations (deletions/duplications) within the SLC26A3 gene"]
Parameters
[{"name": "SLC26A3 Gene Sequencing", "reference_range": "No pathogenic variants detected"}, {"name": "Deletion/Duplication Analysis", "reference_range": "No significant copy number variants detected"}]
Preparation
["No specific fasting required", "Inform the lab of any relevant family history"]
Indications
["Newborn screening for DIAR1", "Diagnosis of suspected DIAR1 based on clinical presentation", "Family screening for carrier status"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81324-1 ICD-10: P78.3
Clinical summary
This diagnostic test evaluates the SLC26A3 gene for pathogenic mutations associated with congenital secretory chloride diarrhea type 1 (DIAR1).
TEST-6153
SLC26A6 Gene Hyperoxaluria Genetic Test

This test identifies mutations in the SLC26A6 gene associated with primary hyperoxaluria type 2, a metabolic disorder leading to kidney stones.

Peripheral whole blood (EDTA) or buccal swab (FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SLC26A6 gene mutations", "Exons and splice sites of the SLC26A6 gene"]
Parameters
[]
Preparation
["No special fasting or diet is required."]
Indications
["Patients with recurrent calcium oxalate kidney stones", "Family screening for hyperoxaluria"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93931-6 ICD-10: E74.81
Clinical summary
This test identifies mutations in the SLC26A6 gene associated with primary hyperoxaluria type 2, a metabolic disorder leading to kidney stones.
TEST-4526
SLC2A1 Gene GLUT1 Deficiency Syndrome Type 1 Genetic Test

This genetic test analyzes the SLC2A1 gene for mutations associated with Glucose Transporter Type 1 Deficiency Syndrome.

Peripheral whole blood (EDTA) or DNA FTA card 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC2A1 gene", "Full gene coverage including intronic and promoter regions"]
Parameters
[]
Preparation
["No specific patient preparation required"]
Indications
["Suspicion of GLUT1 deficiency syndrome", "Early-onset epilepsy", "Paroxysmal exercise-induced dyskinesia", "Cognitive delay", "Low CSF glucose responsive to ketogenic therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 78041-6 ICD-10: E74.8
Clinical summary
This genetic test analyzes the SLC2A1 gene for mutations associated with Glucose Transporter Type 1 Deficiency Syndrome.
TEST-6302
SLC2A5 Gene Fructose Uptake Deficiency Genetic Test

This genetic test evaluates the SLC2A5 gene for variants associated with fructose malabsorption.

Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC2A5 gene", "Fructose transporter (GLUT5) function"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet changes needed prior to sample collection"]
Indications
["Suspected fructose malabsorption", "Gastrointestinal symptoms triggered by fructose-containing foods", "Differential diagnosis from hereditary fructose intolerance (HFI)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90995-1 ICD-10: E74.20
Clinical summary
This genetic test evaluates the SLC2A5 gene for variants associated with fructose malabsorption.
TEST-4533
SLC35C1 Gene Genetic Test (Leukocyte Adhesion Deficiency Type II / CDG Type IIc)

This genetic test evaluates the SLC35C1 gene for pathogenic variants associated with LAD II and CDG Type IIc.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC35C1 gene", "Copy Number Variations (CNV) in SLC35C1"]
Parameters
[{"name": "Diagnostic Sensitivity", "reference_range": "99.9% (via ISO 9001:2015-accredited NGS)"}]
Preparation
["Provide detailed medical history and family pedigree during mandatory genetic counseling", "No special dietary or medication changes required unless directed by physician"]
Indications
["Suspected Leukocyte Adhesion Deficiency Type II", "Suspected Congenital Disorder of Glycosylation Type IIc", "Family history of LAD II or CDG Type IIc"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81319-1 ICD-10: E77.8
Clinical summary
This genetic test evaluates the SLC35C1 gene for pathogenic variants associated with LAD II and CDG Type IIc.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area